Rigerna Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $30M

  • Investors
  • 12

Rigerna General Information

Description

Manufacturer of innovative nucleic acid therapeutics intended to advance treatment for liver and non-liver diseases. The company offers proprietary drug delivery platforms, core nucleic acid technology, and expertise in chemistry, biology, and clinical development, enabling pharmaceutical companies and patients to access highly targeted, effective, and next-generation nucleic acid medicines.

Contact Information

Website
www.rigerna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building B2, Phase I, Biomedical Industrial Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Building B2, Phase I, Biomedical Industrial Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Rigerna Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rigerna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 02-Apr-2026 $30M Completed Generating Revenue
4. Early Stage VC 20-Mar-2026 Completed Generating Revenue
3. Early Stage VC 07-Apr-2025 Completed Generating Revenue
2. Early Stage VC 20-Oct-2024 $14.2M $200M Completed Generating Revenue
1. Seed Round 23-May-2022 Completed Startup
To view Rigerna’s complete valuation and funding history, request access »

Rigerna Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayland Capital Corporate Venture Capital Minority
Delian Capital Venture Capital Minority
Guohai Innovation Capital Investment Management Corporate Venture Capital Minority
Lenovo Capital and Incubator Group Corporate Venture Capital Minority
Guolian Investment Corporate Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Rigerna FAQs

  • When was Rigerna founded?

    Rigerna was founded in 2022.

  • Where is Rigerna headquartered?

    Rigerna is headquartered in Suzhou, China.

  • What industry is Rigerna in?

    Rigerna’s primary industry is Biotechnology.

  • Is Rigerna a private or public company?

    Rigerna is a Private company.

  • What is Rigerna’s current revenue?

    The current revenue for Rigerna is .

  • How much funding has Rigerna raised over time?

    Rigerna has raised $259M.

  • Who are Rigerna’s investors?

    Bayland Capital, Delian Capital, Guohai Innovation Capital Investment Management, Lenovo Capital and Incubator Group, and Guolian Investment are 5 of 12 investors who have invested in Rigerna.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process